{"podcast":{"title":"Neuro-Oncology: The Podcast","slug":"neuro-oncology-the-podcast-1565653","podcast_index_feed_id":1565653,"rss_url":"https://soc-neuro-onc.libsyn.com/rss","website_url":"https://soc-neuro-onc.libsyn.com","image_url":"https://static.libsyn.com/p/assets/e/f/5/2/ef52e509e1640133/Neuro-oncology_Podcast_G2b.jpg","author":"Neuro-Oncology","episode_count":146,"summary":"Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.","last_synced_at":"2026-07-24T20:19:44.205313+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653"},"episode":{"title":"Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma","slug":"neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma","published_at":"2026-05-30T03:03:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma","show_page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653","url":"https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma","audio_url":"https://traffic.libsyn.com/secure/soc-neuro-onc/nop-139.mp3?dest-id=2339594","summary":"Host/Interviewee: ç, PhD Candidate, UT Health San Antonio Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01, a personalized multivalent neoantigen DNA vaccine administered following surgical resection and radiation in patients with MGMT unmethylated glioblastoma, with findings published in Nature Cancer on May 12th, 2026.","meta_description":"Host/Interviewee: ç, PhD Candidate, UT Health San Antonio Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01,…","key_points":[],"chapters":[],"topics":[],"duration_seconds":199,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}